These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8172795)

  • 1. Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.
    Hürny C; Bernhard J; Coates A; Castiglione M; Peterson HF; Gelber RD; Rudenstam CM; Goldhirsch A; Senn HJ
    Ann Oncol; 1994 Jan; 5(1):65-74. PubMed ID: 8172795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.
    Hürny C; Bernhard J; Coates AS; Castiglione-Gertsch M; Peterson HF; Gelber RD; Forbes JF; Rudenstam CM; Simoncini E; Crivellari D; Goldhirsch A; Senn HJ
    Lancet; 1996 May; 347(9011):1279-84. PubMed ID: 8622502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
    Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Goldhirsch A; Senn HJ; Rudenstam CM
    Ann Oncol; 1997 Sep; 8(9):825-35. PubMed ID: 9358933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.
    Hürny C; Bernhard J; Gelber RD; Coates A; Castiglione M; Isley M; Dreher D; Peterson H; Goldhirsch A; Senn HJ
    Eur J Cancer; 1992; 28(1):118-24. PubMed ID: 1567662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
    Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Galligioni E; Marini G; Thürlimann B; Forbes JF; Goldhirsch A; Senn HJ; Rudenstam CM
    Br J Cancer; 1998 Sep; 78(5):686-93. PubMed ID: 9744512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.
    Coates AS; Hürny C; Peterson HF; Bernhard J; Castiglione-Gertsch M; Gelber RD; Goldhirsch A
    J Clin Oncol; 2000 Nov; 18(22):3768-74. PubMed ID: 11078489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life assessment in the International Breast Cancer Study Group: past, present, and future.
    Hürny C; Bernhard J; Coates A
    Recent Results Cancer Res; 1998; 152():390-5. PubMed ID: 9928574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.
    Bernhard J; Peterson HF; Coates AS; Gusset H; Isley M; Hinkle R; Gelber RD; Castiglione-Gertsch M; Hürny C
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):587-601. PubMed ID: 9549808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).
    Bernhard J; Hürny C; Maibach R; Herrmann R; Laffer U
    Ann Oncol; 1999 Jul; 10(7):775-82. PubMed ID: 10470423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-of-life changes over time in breast cancer patients undergoing breast-conserving surgery: a prospective study in Greece.
    Eskitzis P; Zafrakas M; Papanicolaou A; Panagopoulou E; Gkoutzioulis M; Sympilidis G; Tarlatzis BC
    Arch Gynecol Obstet; 2016 Sep; 294(3):639-45. PubMed ID: 27086287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    ; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
    J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.
    Coates A; Gebski V; Signorini D; Murray P; McNeil D; Byrne M; Forbes JF
    J Clin Oncol; 1992 Dec; 10(12):1833-8. PubMed ID: 1453197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).
    Hürny C; Bernhard J; Bacchi M; van Wegberg B; Tomamichel M; Spek U; Coates A; Castiglione M; Goldhirsch A; Senn HJ
    Support Care Cancer; 1993 Jul; 1(4):200-8. PubMed ID: 8193882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.
    Gelber RD; Bonetti M; Cole BF; Gelber S; Goldhirsch A
    Recent Results Cancer Res; 1998; 152():373-89. PubMed ID: 9928573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
    Bernhard J; Thürlimann B; Schmitz SF; Castiglione-Gertsch M; Cavalli F; Morant R; Fey MF; Bonnefoi H; Goldhirsch A; Hürny C
    J Clin Oncol; 1999 Jun; 17(6):1672-9. PubMed ID: 10561203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the quality of life--a study in newly-diagnosed breast cancer patients.
    Ganz PA; Schag CA; Cheng HL
    J Clin Epidemiol; 1990; 43(1):75-86. PubMed ID: 2319284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life evolution in elderly survivors with localized breast cancer treated with radiotherapy over a three-year follow-up.
    Arraras JI; Manterola A; Illarramendi JJ; Asin G; de la Cruz S; Ibañez B; Galbete A; Salgado E; Zarandona U; Vera R; Dominguez MA; Martinez E
    Breast; 2018 Oct; 41():74-81. PubMed ID: 30007271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
    Saha P; Regan MM; Pagani O; Francis PA; Walley BA; Ribi K; Bernhard J; Luo W; Gómez HL; Burstein HJ; Parmar V; Torres R; Stewart J; Bellet M; Perelló A; Dane F; Moreira A; Vorobiof D; Nottage M; Price KN; Coates AS; Goldhirsch A; Gelber RD; Colleoni M; Fleming GF; ; ;
    J Clin Oncol; 2017 Sep; 35(27):3113-3122. PubMed ID: 28654365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.